###begin article-title 0
###xml 50 51 50 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 75 90 75 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 75 90 <span type="species:ncbi:1773">M. tuberculosis</span>
Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection
###end article-title 0
###begin p 1
###xml 30 46 30 46 <email xmlns:xlink="http://www.w3.org/1999/xlink">pamere@mskcc.org</email>
###xml 71 89 71 89 <email xmlns:xlink="http://www.w3.org/1999/xlink">glickman@mskcc.org</email>
CORRESPONDENCE Eric G. Pamer: pamere@mskcc.org OR Michael S. Glickman: glickman@mskcc.org
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 0 26 0 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis</italic>
###xml 212 227 212 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 402 417 402 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 477 478 477 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 492 507 492 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 716 717 716 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 963 978 963 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 1159 1174 1159 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 1349 1364 1349 1364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 0 26 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 212 227 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 402 417 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 492 507 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
###xml 539 554 <span type="species:ncbi:10090">transgenic mice</span>
###xml 963 978 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1139 1143 <span type="species:ncbi:10090">mice</span>
###xml 1159 1174 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1349 1364 <span type="species:ncbi:1773">M. tuberculosis</span>
Mycobacterium tuberculosis infection induces complex CD4 T cell responses that include T helper type 1 (Th1) cells and regulatory T cells. Although Th1 cells control infection, they are unable to fully eliminate M. tuberculosis, suggesting that Th1-mediated immunity is restrained from its full sterilizing potential. Investigation into T cell-mediated defense is hindered by difficulties in expanding M. tuberculosis-specific T cells. To circumvent this problem, we cloned CD4+ T cells from M. tuberculosis-infected B6 mice and generated transgenic mice expressing a T cell receptor specific for the immunodominant antigen early secreted antigenic target 6 (ESAT-6). Adoptively transferred naive ESAT-6-specific CD4+ T cells are activated in pulmonary lymph nodes between 7 and 10 d after aerosol infection and undergo robust expansion before trafficking to the lung. Adoptive transfer of activated ESAT-6-specific Th1 cells into naive recipients before aerosol M. tuberculosis infection dramatically enhances resistance, resulting in 100-fold fewer bacteria in infected lungs. However, despite large numbers of Th1 cells in the lungs of mice at the time of M. tuberculosis challenge, protection was not manifested until after 7 d following infection. Our results demonstrate that pathogen-specific Th1 cells can provide protection against inhaled M. tuberculosis, but only after the first week of infection.
###end p 3
###begin p 4
Abbreviations used: BCG, Bacille Calmette-Guerin; ESAT-6, early secreted antigenic target 6; pLN, pulmonary LN; tg, transgenic.
###end p 4
###begin p 5
###xml 0 26 0 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis</italic>
###xml 266 267 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 268 269 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 315 330 307 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 480 495 472 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 540 541 532 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 542 543 534 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 580 595 572 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 601 609 593 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. bovis</italic>
###xml 693 694 685 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 798 813 778 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 0 26 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 290 296 <span type="species:ncbi:9606">humans</span>
###xml 301 305 <span type="species:ncbi:10090">mice</span>
###xml 315 330 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 480 495 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 580 595 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 601 609 <span type="species:ncbi:29425|species:ncbi:476|species:ncbi:28903|species:ncbi:1765">M. bovis</span>
###xml 713 717 <span type="species:ncbi:10090">mice</span>
###xml 798 813 <span type="species:ncbi:1773">M. tuberculosis</span>
Mycobacterium tuberculosis is an inhaled pathogen that primarily infects macrophages and DCs. Bacterial replication in infected cells is inhibited by the actions of IFN-gamma and TNF-alpha, supplied by antigen-specific T cells and cells of the innate immune system (1-5). Although infected humans and mice generate M. tuberculosis-specific T cells, the immune system is generally incapable of providing sterilizing immunity against this pathogen, and individuals cured of primary M. tuberculosis infection remain vulnerable to reinfection (6-8). The only approved vaccine against M. tuberculosis, the M. bovis derivative Bacille Calmette-Guerin (BCG), induces, at best, only partial immunity (9). Immunization of mice with BCG induces protective immunity that results in approximately10-fold fewer M. tuberculosis organisms in the lungs upon aerosol challenge.
###end p 5
###begin p 6
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 49 64 49 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 176 177 176 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 355 370 355 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 435 436 435 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 448 449 448 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 712 713 700 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 714 715 702 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 902 917 890 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 49 64 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 199 207 <span type="species:ncbi:9606">patients</span>
###xml 240 243 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 349 353 <span type="species:ncbi:10090">mice</span>
###xml 355 370 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 519 525 <span type="species:ncbi:9606">humans</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
###xml 902 917 <span type="species:ncbi:1773">M. tuberculosis</span>
CD4+ T cells play a dominant role in immunity to M. tuberculosis because animals deficient in these cells are more susceptible to infection than normal mice or mice lacking CD8+ T cells (10-12), and patients with CD4 T cell deficiency from HIV infection have dramatically elevated rates of reactivation tuberculosis (13). After aerosol infection in mice, M. tuberculosis replication is controlled when effector T cells reach the lung (6). Among CD4+ T cell subsets, IFN-gamma-producing Th1 cells are essential, because humans with defects in the IFN-gamma receptor have markedly increased susceptibility to mycobacterial infections, and mice lacking either IFN-gamma or its receptor die rapidly after infection (2-4). Although it is commonly assumed that vaccines that elicit larger or more Th1-focused antigen-specific T cell responses will be more effective, the extent to which very high numbers of M. tuberculosis-specific Th1 cells can provide protective immunity remains unclear.
###end p 6
###begin p 7
###xml 49 64 49 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 127 142 127 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 485 500 485 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 49 64 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 127 142 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 485 500 <span type="species:ncbi:1773">M. tuberculosis</span>
Two hypotheses have been proposed to explain how M. tuberculosis evades T cell-mediated immune defenses. The first posits that M. tuberculosis induces complex T cell responses comprising Th1 and Th17 effector cells that enhance bacterial clearance, and regulatory T cells that restrict bacterial clearance (14-16). In this scenario, regulatory T cell function is sufficient to prevent clearance of primary infection or development of protective immunity. The second hypothesis is that M. tuberculosis has acquired mechanisms to hide from the immune system within infected cells, out of reach of the adaptive immune system. These hypotheses are not mutually exclusive and evidence in support of both is mounting. Because tuberculosis is a lengthy infection, with clinically distinct phases, it is likely that the mechanisms of immune evasion differ during early, latent, and late infection. Determining the relative contributions of distinct immune evasion mechanisms is essential for vaccine design and new therapeutic approaches.
###end p 7
###begin p 8
###xml 55 70 55 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 218 233 218 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 600 615 600 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 681 696 681 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 780 781 780 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 836 837 836 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 55 70 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 218 233 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 600 615 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 681 696 <span type="species:ncbi:1773">M. tuberculosis</span>
In this study, we investigated whether high numbers of M. tuberculosis-specific Th1 cells can protect mice from infection. We generated mice that are transgenic (tg) for an MHC class II-restricted TCR specific for the M. tuberculosis antigen early secreted antigenic target 6 (ESAT-6). We show that ESAT-6-specific Th1 cells are remarkably potent in protecting mice from infection. However, ESAT-6-specific Th1 cells controlled bacterial replication only after day 7 following infection, despite the fact that high numbers of these cells were in the lung before, during, and after inhalation of live M. tuberculosis. These studies indicate that during the first week of infection, M. tuberculosis-infected cells are either physically inaccessible to pathogen-specific effector CD4+ T cells or are functionally incapable of receiving CD4+ T cell help.
###end p 8
###begin title 9
RESULTS
###end title 9
###begin title 10
###xml 37 41 <span type="species:ncbi:10090">mice</span>
Generation of ESAT-6-specific TCR tg mice
###end title 10
###begin p 11
###xml 43 58 43 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 179 180 179 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 222 223 222 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 243 258 243 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 322 326 322 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3-15</sub>
###xml 348 349 348 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 431 432 431 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 518 533 518 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 542 543 542 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 649 657 649 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 686 687 686 687 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1038 1040 1007 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 43 58 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 101 107 <span type="species:ncbi:9606">humans</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 243 258 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
###xml 518 533 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 974 979 <span type="species:ncbi:9606">human</span>
ESAT-6 is a secreted protein implicated in M. tuberculosis pathogenesis (17) and is a key antigen in humans, primates, and mice, and vaccination with ESAT-6 induces protective CD4+ T cell immunity (18-22). To study the CD4+ T cell response to M. tuberculosis, tg mice for an MHC class II-restricted TCR specific for ESAT-63-15 in the context of I-Ab were generated. To isolate a TCR that is functional during in vivo infection, CD4+ T cells specific for ESAT-6 were harvested from mice that were aerosol infected with M. tuberculosis, and CD4+ T cell hybridomas were generated. The specificity of one ESAT-6-specific hybridoma, clone 7, is shown in Fig. 1 A. The TCR used by clone 7 CD4+ hybridoma cells was composed of a TCR beta chain generated from Vbeta10b-Dbeta1-Jbeta2.4 gene segments and a TCR alpha chain generated from Valpha11.2-Jalpha27 gene segments (unpublished data). TCR alpha and beta chain cDNAs were cloned into the VA hCD2 cassette vector, which uses the human CD2 promoter to drive the expression of cDNAs in T cells (23).
###end p 11
###begin p 12
###xml 13 14 13 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C7 TCR tg CD4<sup>+</sup> T cells are specific to ESAT-6.</bold>
###xml 518 519 510 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 537 538 529 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 612 613 604 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 667 668 659 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 778 779 770 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 845 846 837 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 973 974 965 966 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 570 574 <span type="species:ncbi:10090">mice</span>
###xml 630 634 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
###xml 809 813 <span type="species:ncbi:10090">mice</span>
###xml 876 880 <span type="species:ncbi:10090">mice</span>
C7 TCR tg CD4+ T cells are specific to ESAT-6. (A) Clone 7 hybridoma cells or hybridoma fusion partner BW5147 cells were stimulated with 5 mug/ml of ESAT-6 peptide, or with media in the presence of APCs. Supernatants were collected 2 d later, and IL-2 levels were measured by ELISA. nd, not detectable. (B) Splenocytes and thymocytes from B6 or C7 TCR tg mice were stained for CD4 and CD8 expression. Numbers indicate the percentages of cells in each gate. (C) Vbeta10b and Valpha11.1/.2 expression after gating on CD4+ thymocytes or CD4+ splenocytes from the indicated mice. Shaded gray histograms represent CD4+ T cells from B6 mice; continuous lines represents CD4+ T cells from C7 TCR tg mice. Black and small gray numbers indicate the percentages of stained cells among CD4+ T cells from C7 TCR tg or B6 mice, respectively. (D) Purified CD4+ T cells from C7 TCR tg or B6 mice were stimulated with ESAT-6 peptide in the presence of APCs. Proliferation was measured by [3H]thymidine incorporation between 48 and 72 h of culture. Error bars in A and D represent SDs.
###end p 12
###begin p 13
###xml 126 127 126 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 269 270 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 330 331 330 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 354 362 354 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 384 385 384 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 471 479 464 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 C</xref>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Because the TCR used to generate ESAT-6-specific TCR tg mice (referred to hereafter as C7 TCR tg mice) was isolated from a CD4+ T cell, an increased frequency of this lineage in tg animals was expected. In both thymocytes and splenocytes, an increased percentage of CD4+ T cells with a concomitant decrease in the frequency of CD8+ T cells was observed (Fig. 1 B). The majority of CD4+ thymocytes and splenocytes expressed the transgene-encoded TCR alpha and beta chain (Fig. 1 C).
###end p 13
###begin p 14
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 191 192 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 298 299 298 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 352 360 352 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 D</xref>
###xml 401 402 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 448 452 448 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3-15</sub>
###xml 456 457 456 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 501 502 501 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 537 552 537 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
###xml 537 552 <span type="species:ncbi:1773">M. tuberculosis</span>
To confirm the specificity of these cells, CD4+ T cells were purified from C7 TCR tg mice or B6 control animals and were stimulated with titrating amounts of ESAT-6 peptide. Although both CD4+ T cell populations proliferated similarly to anti-CD3/CD28 stimulation (not depicted), only C7 TCR tg CD4+ T cells proliferated in response to ESAT-6 peptide (Fig. 1 D). In summary, C7 TCR tg mice contain CD4+ T cells that express a TCR specific to ESAT-63-15-I-Ab complexes. This TCR was isolated from a CD4+ T cell clone responding to a live M. tuberculosis infection.
###end p 14
###begin title 15
###xml 13 14 13 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 59 74 59 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 59 74 <span type="species:ncbi:1773">M. tuberculosis</span>
C7 TCR tg CD4+ T cells differentiate into Th1 cells during M. tuberculosis infection
###end title 15
###begin p 16
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 116 117 116 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 137 138 137 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 174 177 174 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 288 303 288 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 317 325 317 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 371 372 371 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 493 494 493 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 571 586 571 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, A and B</xref>
###xml 701 702 701 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 745 753 745 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 C</xref>
###xml 842 843 834 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 890 898 882 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 D</xref>
###xml 1055 1063 1047 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 E</xref>
###xml 1091 1092 1083 1084 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 288 303 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 448 452 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
To determine whether C7 TCR tg CD4+ T cells respond to ESAT-6 antigen generated during aerosol infection of mice, 104 naive C7 TCR tg CD4+ T cells (on a RAG-1-deficient [RAG -/-] background) were adoptively transferred into B6 recipients that were aerosol infected 1 d later with 100 CFU M. tuberculosis. The data in Fig. 2 A show that at this T cell dosage, naive C7 CD4+ T cells (congenically marked with CD90.1) are not detectable in uninfected mice. In contrast, marked expansion of C7 CD4+ T cells is noted in the pulmonary LNs (pLNs) of mice infected 12 d earlier (Fig. 2, A and B). Analysis of pLNs, spleen, and lung between days 12 and 18 of infection demonstrates that the frequency of C7 CD4+ T cells increases in the lung and spleen (Fig. 2 C). Staining for intracellular TNF-alpha and IFN-gamma demonstrates that responding C7 CD4+ T cells acquired Th1 effector cell functions (Fig. 2 D). The differentiation of responding cells into Th1 effector cells is further supported by their expression of T-bet, as measured by intracellular staining (Fig. 2 E). In contrast, naive C7 CD4+ T cells did not differentiate into regulatory T cells because the transcription factor Foxp3 was not expressed (unpublished data).
###end p 16
###begin p 17
###xml 13 14 13 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 34 49 34 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C7 TCR tg CD4<sup>+</sup> T cells respond to <italic>M. tuberculosis</italic> infection in vivo.</bold>
###xml 75 76 75 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 97 98 97 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 305 308 305 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 312 313 312 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 329 330 329 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 411 412 411 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 529 544 529 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 728 731 728 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 735 736 735 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1038 1041 1030 1033 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1045 1046 1037 1038 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 34 49 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 463 467 <span type="species:ncbi:10090">mice</span>
###xml 529 544 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 664 668 <span type="species:ncbi:10090">mice</span>
###xml 807 811 <span type="species:ncbi:10090">mice</span>
###xml 1200 1204 <span type="species:ncbi:10090">mice</span>
C7 TCR tg CD4+ T cells respond to M. tuberculosis infection in vivo. (A) 104 C7 TCR tg.RAG-/- CD4+ T cells (CD90.1) were transferred into uninfected congenically marked B6 recipients (CD90.2), and splenocytes were stained for CD4 and CD90.1 expression 7 d later. The gate marks donor-derived C7 TCR tg.RAG-/- CD4+ T cells (CD90.1+) cells, and the percentages of these cells within total cells (top) or among CD4+ T cells (bottom) are shown. (B-E) As in A, except mice were aerosol infected 1 d after T cell transfer with 100 CFU M. tuberculosis. pLNs, spleen, and lung were examined 12, 15, and 18 d later. (C) Graphic representation of results from three to four mice per time point. Error bars represent SDs. (D) C7 TCR tg.RAG-/- CD4+ T cells from the indicated organs were harvested from day 15-infected mice, and their ability to make IFN-gamma and TNF-alpha was determined after stimulation with ESAT-6 peptide or medium alone. (E) Intracellular T-bet (shaded histogram) or isotype control staining (continuous line) of C7 TCR tg.RAG-/- CD4+ T cells taken from the indicated organs 15 d after infection. The data presented in this figure are representative of two experiments with three to four mice per group.
###end p 17
###begin p 18
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 107 122 107 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 249 250 249 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 107 122 <span type="species:ncbi:1773">M. tuberculosis</span>
These experiments demonstrate that naive C7 CD4+ T cells are activated in vivo in the setting of pulmonary M. tuberculosis infection and that they traffic from draining LNs to the lung. Furthermore, these studies demonstrate that naive C7 TCR tg CD4+ T cells differentiate into Th1 effector cells, as is observed with polyclonal ESAT-6-specific T cell responses (24).
###end p 18
###begin title 19
T cell priming occurs between days 7 and 10 after infection
###end title 19
###begin p 20
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 44 59 44 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 587 602 587 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 624 625 624 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 787 789 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 790 792 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 984 985 972 973 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 995 997 983 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 999 1001 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 44 59 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 587 602 <span type="species:ncbi:1773">M. tuberculosis</span>
The ESAT-6-specific CD4+ T cell response to M. tuberculosis has been measured in functional ways via ELISA, ELISPOT, or intracellular cytokine staining in mice with a complex TCR repertoire (24, 25). One limitation of relying on these methods is that the frequency of antigen-specific cells needs to be high enough to detect by fluorimetric analysis, and these cells need to produce cytokines to be detected. Accordingly, naive cells cannot be studied because these cells need to expand and differentiate into cytokine-producing cells before they can be visualized. Using these methods, M. tuberculosis-specific effector CD4+ T cells are first detectable in the pLNs approximately14 d after infection, and these cells reach peak numbers in the lungs between 21 and 28 d after infection (24-26). Because the delay in recruitment of effector cells to the lung is not a general characteristic of pulmonary infections, we wanted to determine the kinetics of priming of ESAT-6-specific CD4+ T cells (27, 28).
###end p 20
###begin p 21
###xml 44 45 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 111 126 111 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 130 131 130 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 164 167 164 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 171 172 171 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 292 307 292 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 409 410 409 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 485 486 485 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 569 570 569 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 691 699 691 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 841 842 841 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 957 958 957 958 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 976 977 976 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1205 1206 1205 1206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1256 1257 1244 1245 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1420 1428 1408 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 A</xref>
###xml 1490 1491 1478 1479 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1513 1514 1501 1502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1547 1555 1535 1543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 B</xref>
###xml 1629 1630 1617 1618 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 111 126 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
###xml 292 307 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1027 1032 <span type="species:ncbi:10090">mouse</span>
To understand when naive ESAT-6-specific CD4+ T cells are first presented antigen after aerosol infection with M. tuberculosis, 105 CFSE-labeled naive C7 TCR tg.RAG-/- CD4+ T cells (CD90.1) were transferred into B6 recipients (CD90.2), and recipient mice were infected 1 d later with 100 CFU M. tuberculosis. At days 7, 10, and 13 after infection, pLNs were recovered and the frequency and phenotype of C7 CD4+ T cells were determined. At day 7 after infection, the frequency of C7 CD4+ T cells in the pLNs was low and similar to that seen in uninfected animals. C7 CD4+ T cells at day 7 had a naive phenotype. These cells were CFSE bright, CD69 negative, CD44 intermediate, and CD62L high (Fig. 3 A and not depicted). The naive phenotype of these cells, with low surface expression of the early activation marker CD69, indicates that C7 CD4+ T cells had not been presented antigen at the day 7 time point. By day 10 after infection, the frequency of C7 CD4+ T cells among CD4+ T cells increased compared with day 7, and every mouse examined contained either recently activated cells (expressing CD69) or divided cells, as indicated by CFSE dilution. At day 13 after infection, the frequency of the C7 CD4+ T cells increased to approximately6% of total CD4+ T cells. These cells were mostly CFSE negative and displayed an effector/memory-like cell-surface phenotype, expressing high levels CD44 and low levels of CD62L (Fig. 3 A and not depicted). The temporal change in frequency of C7 CD4+ T cells among the CD4+ T cells in the pLNs is shown in Fig. 3 B. These experiments indicate that the priming of naive ESAT-6-specific CD4+ T cells is delayed compared with other respiratory infections and occurs between days 7 and 10 after infection.
###end p 21
###begin p 22
###xml 19 20 19 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 0 93 0 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Naive C7 TCR tg CD4<sup>+</sup> T cells are activated in the pLNs between days 7 and 10 after infection.</bold>
###xml 100 101 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 128 131 128 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 135 136 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 295 310 295 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 458 461 458 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 465 466 465 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 482 483 482 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 556 557 556 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 706 709 706 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 713 714 713 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 295 310 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 847 851 <span type="species:ncbi:10090">mice</span>
###xml 1037 1041 <span type="species:ncbi:10090">mice</span>
Naive C7 TCR tg CD4+ T cells are activated in the pLNs between days 7 and 10 after infection. (A) 105 CFSE-labeled C7 TCR tg.RAG-/- CD4+ T cells (CD90.1) were transferred into congenically marked B6 recipients (CD90.2) that were left uninfected (top row, naive) or aerosol infected with 100 CFU M. tuberculosis 1 d later (bottom three rows, after infection). The first column shows CD4 and CD90.1 staining of pLN cells. Gate marks donor-derived C7 TCR tg.RAG-/- CD4+ T cells (CD90.1+), and the percentage of these cells within total pLNs (top) or among CD4+ T cells (bottom) is shown. The second and third columns show CFSE intensity and CD69 staining or CD44 staining, respectively, on gated C7 TCR tg.RAG-/- CD4+ T cells. Numbers indicate the percentages of cells in the indicated gates. (B) Graphic representation of results from three to four mice per time point for the experiment described in A. Error bars represent SDs. The data presented in this figure are representative of three experiments of similar design with two to four mice per group.
###end p 22
###begin title 23
###xml 30 34 <span type="species:ncbi:10090">mice</span>
C7 Th1 effector cells protect mice from infection
###end title 23
###begin p 24
###xml 20 35 20 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 77 92 77 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 161 176 161 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 237 252 237 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 265 266 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 274 275 274 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 322 323 322 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 594 609 582 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 650 652 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 20 35 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 77 92 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 161 176 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 237 252 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 594 609 <span type="species:ncbi:1773">M. tuberculosis</span>
Mice immunized with M. tuberculosis proteins plus adjuvant, BCG variants, or M. tuberculosis are, in comparison to naive controls, protected from challenge with M. tuberculosis. These immunization protocols induce complex populations of M. tuberculosis-specific CD4+ and CD8+ T cells that contribute to protection. The CD4+ T cell populations are mixed and may include Th1, Th17, and suppressive regulatory T cell populations (14-16). In one report, in vitro-generated monoclonal Th1 cells (specific to ovalbumin) were shown to provide approximately1 log of protection in animals infected with M. tuberculosis expressing the model antigen ovalbumin (29).
###end p 24
###begin p 25
###xml 27 42 27 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 226 227 226 227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 319 334 319 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 458 466 458 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 A</xref>
###xml 748 756 748 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 837 852 837 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 898 899 898 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 903 904 903 904 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 911 912 911 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 1156 1157 1156 1157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 1264 1279 1264 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, C and D</xref>
###xml 1482 1483 1482 1483 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 1498 1506 1498 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 D</xref>
###xml 27 42 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
###xml 319 334 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 719 723 <span type="species:ncbi:10090">mice</span>
###xml 837 852 <span type="species:ncbi:1773">M. tuberculosis</span>
Because ESAT-6 is a native M. tuberculosis antigen and a target for vaccine development (30), we wanted to understand if a pure population of ESAT-6-specific C7 Th1 cells could protect mice from infection. B6 hosts received 107 in vitro-generated C7 Th1 cells (or control Th1 cells) and were then infected with 100 CFU M. tuberculosis 1 d later. Before transfer, the differentiation status of the cells was verified by analysis of CD44 and T-bet expression (Fig. 4 A). 24 d after infection, the number of bacteria in the lungs was determined. Surprisingly, C7 Th1 cells decreased the number of viable bacteria by a factor of 100, whereas animals that received control Th1 cells contained similar numbers of bacteria as mice that received no cells (Fig. 4 B). Next, we sought to determine if fewer C7 Th1 cells could protect animals from M. tuberculosis challenge. Graded numbers of C7 Th1 cells (105, 106, or 107) were transferred into B6 recipients, and bacterial numbers were determined 16, 30, and 90 d after infection. These results show that the degree of protection correlates with the dose of C7 Th1 cells transferred. Administration of as few as 105 cells was sufficient to provide significant protection that was sustained for up to 90 d after infection (Fig. 4, C and D). Interestingly, although the day 30 numbers of bacteria were maintained until day 90 after infection in animals that received low doses of cells, bacterial numbers increased in animals that received 107 C7 Th1 cells (Fig. 4 D).
###end p 25
###begin p 26
###xml 58 73 58 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Adoptive transfer of C7 Th1 T cells confers protection to <italic>M. tuberculosis</italic>.</bold>
###xml 91 92 91 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 317 318 313 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 483 484 479 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 516 517 512 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 608 623 604 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 999 1000 995 996 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 1004 1005 1000 1001 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1012 1013 1008 1009 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 1352 1353 1348 1349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 1382 1383 1378 1379 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1403 1404 1399 1400 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 58 73 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 608 623 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 726 731 <span type="species:ncbi:10090">mouse</span>
###xml 767 771 <span type="species:ncbi:10090">mice</span>
###xml 809 813 <span type="species:ncbi:10090">mice</span>
###xml 1163 1167 <span type="species:ncbi:10090">mice</span>
###xml 1222 1227 <span type="species:ncbi:10090">mouse</span>
###xml 1263 1267 <span type="species:ncbi:10090">mice</span>
###xml 1326 1330 <span type="species:ncbi:10090">mice</span>
Adoptive transfer of C7 Th1 T cells confers protection to M. tuberculosis. (A) B6 or C7 CD4+ T cells were stimulated in vitro with anti-CD3/CD28 (control Th1 cells) or ESAT-6 peptide (C7 Th1 cells), respectively, in the presence of IFN-gamma and anti-IL-4 for 4 d, and were analyzed for CD44 and T-bet expression. CD4+ T cells from naive B6 spleens are shown as a staining control. Numbers represent the percentages of cells in each quadrant. MFI, mean fluorescence intensity. (B) 107 Th1-differentiated B6 or C7 CD4+ T cells were transferred into B6 recipient mice 1 d before aerosol infection with 100 CFU M. tuberculosis. 24 d later, the number of bacteria in the lungs was determined. Each symbol represents data from one mouse, and p-values compare the CFU from mice that received no cells compared with mice that received either B6 or C7 Th1 cells. The experiment was performed two times with similar results. Horizontal bars represent the mean. (C and D) Similar experiment as in B, except 107, 106, or 105 C7 Th1 cells or no cells were transferred and CFU were determined 16, 30, and 90 d after infection. This experiment was preformed one time with four mice per group. In C, each circle represents data from one mouse, and p-values compare the CFU from mice that received no cells. In D, each symbol represents four mice per group (square, 107 cells; inverted triangle, 106 cells; triangle, 105 cells; and circle, no cells). Error bars represent SDs.
###end p 26
###begin p 27
###xml 91 106 91 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 173 174 173 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 91 106 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
These studies demonstrate that ESAT-6-specific Th1 cells can greatly reduce the numbers of M. tuberculosis in the lungs. Compared with control mice, animals that received 107 C7 Th1 cells had a 99% reduction in the number of viable bacteria early after infection.
###end p 27
###begin title 28
C7 Th1 cells control bacterial replication after 1 wk following infection
###end title 28
###begin p 29
###xml 94 95 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 284 291 284 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Figs. 2</xref>
###xml 296 297 296 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">3</xref>
###xml 403 418 403 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 651 653 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 654 656 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 403 418 <span type="species:ncbi:1773">M. tuberculosis</span>
Use of C7 TCR tg cells in the previous experiments demonstrated that naive ESAT-6-specific CD4+ T cells were primed in the pLNs between 7 and 10 d after infection, and these cells differentiated into Th1 effector cells and trafficked to the lungs between 12 and 14 d after infection (Figs. 2 and 3). These observations are consistent with other studies that have measured endogenous T cell responses to M. tuberculosis and demonstrated that antigen-specific T cell responses were detected in the pLNs 14 d after infection, and reached peak numbers in the lungs approximately28 d after infection, at which time in vivo bacterial growth was controlled (24-26).
###end p 29
###begin p 30
###xml 306 307 306 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 382 397 382 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 510 511 498 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 668 679 648 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, A&#8211;C</xref>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 382 397 <span type="species:ncbi:1773">M. tuberculosis</span>
Our experiments with in vitro-generated C7 Th1 cells demonstrated that these cells greatly reduced the bacterial numbers in the lungs as early as day 16 after infection. In the ensuing experiments, we wanted to look earlier than day 16 after infection to determine when C7 Th1 cells manifest protection. 107 C7 Th1 cells were transferred into mice that were infected 1 d later with M. tuberculosis, and bacterial numbers in the lungs were determined early after infection. Before infection, approximately5 x 105 C7 Th1 cells were recovered from either spleen or lungs, and these cells were functional, producing both IFN-gamma and TNF-alpha after ex vivo stimulation (Fig. 5, A-C).
###end p 30
###begin p 31
###xml 34 49 34 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 0 87 0 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C7 Th1 cells confer protection to <italic>M. tuberculosis</italic> only after day 7 following infection.</bold>
###xml 96 97 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 719 734 711 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 34 49 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 484 489 <span type="species:ncbi:10090">mouse</span>
###xml 661 665 <span type="species:ncbi:10090">mice</span>
###xml 719 734 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 910 914 <span type="species:ncbi:10090">mice</span>
###xml 979 983 <span type="species:ncbi:10090">mice</span>
###xml 1088 1092 <span type="species:ncbi:10090">mice</span>
C7 Th1 cells confer protection to M. tuberculosis only after day 7 following infection. (A-C) 107 C7 Th1 cells (CD90.1) were transferred into B6 recipient mice (CD90.2), and 1 d later splenocytes or lung cells were harvested and stained for CD4 and CD90.1 expression. (A) Gate marks donor-derived cells among total cells in the indicated organs. (B) Graphic representation showing the number of recoverable C7 Th1 cells from the indicated organs. Each symbol represents data from one mouse. (C) Intracellular TNF-alpha and IFN-gamma staining of C7 Th1 cells harvested from the lungs. bars in B and C represent the mean. (D) Similar experiment as in A-C, except mice were infected 1 d after T cell transfer with 100 CFU M. tuberculosis. Bacterial numbers were determined at the indicated days after infection. The data presented is a compilation of five experiments. Each time point includes CFU data from 7-12 mice per time point with the exception of days 4 and 5, which have 4 mice per time point. Error bars represent SDs. (E) Lung cells were harvested from day 16- or day 30-infected mice and were stained for CD4 and CD90.1 expression (left). Gate marks donor-derived cells among total cells. Intracellular TNF-alpha and IFN-gamma staining of C7 Th1 cells harvested from the lungs is shown (right).
###end p 31
###begin p 32
###xml 550 565 550 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, D and E</xref>
###xml 316 320 <span type="species:ncbi:10090">mice</span>
To our surprise, despite the high numbers of C7 effector cells in the lungs, similar numbers of bacteria were recovered from animals that received C7 Th1 cells and from control animals during the first 7 d of infection. In contrast, between days 7 and 10 after infection, while bacterial growth continued in control mice, growth was controlled in animals that received C7 Th1 cells. Interestingly, the number of bacteria remained constant until day 30 after infection despite the presence of C7 Th1 cells capable of producing cytokines in the lungs (Fig. 5, D and E).
###end p 32
###begin p 33
###xml 792 794 780 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 1124 1132 1112 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifn&#947;</italic>
###xml 1154 1158 1138 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nos2</italic>
###xml 990 994 <span type="species:ncbi:10090">mice</span>
###xml 1186 1190 <span type="species:ncbi:10090">mice</span>
The finding that C7 Th1 cells were in the lungs before infection, but did not control bacterial replication until after day 7 following infection, led us to investigate whether these cells were activated during the first week of infection. Unlike our studies using naive C7 cells, we could not determine, using the activation markers CD69 and CD25, when C7 Th1 effector cells were presented antigen in the lung, because approximately60% of C7 Th1 cells expressed these activation markers regardless of whether these cells were harvested from naive or infected animals (Fig. S1, available at ). This result is consistent with studies of memory CD8 T cells in the lung and suggests that CD69 cannot be used to monitor presentation of cognate antigen to antigen-experienced T cells in the lung (31). In addition, expansion of C7 Th1 cells was not evident in infected animals between days 4 and 13 after infection, because similar numbers of C7 Th1 cells were recovered from naive and infected mice (Fig. S1). As a third attempt to understand if C7 Th1 cells were activated during the first 7 d of infection, message levels for ifngamma and one target gene, nos2, were measured in infected mice that received C7 Th1 cells. Similar levels of these transcripts were observed from days 1 to 7 after infection, whereas both transcripts were induced by day 18 after infection. This suggests that C7 Th1 cells were not activated to produce high levels of IFN-gamma during the first week of infection. Collectively, these data do not support the hypothesis that C7 Th1 cells are activated during the first 7 d of infection. However, these negative data also do not rule out the possibility that some C7 Th1 cells (perhaps very small numbers) "see" antigen and are activated during the first week of infection.
###end p 33
###begin p 34
###xml 105 120 105 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 454 469 454 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 530 545 530 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 651 653 651 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 655 657 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 105 120 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 427 431 <span type="species:ncbi:10090">mice</span>
###xml 454 469 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 530 545 <span type="species:ncbi:1773">M. tuberculosis</span>
In summary, the results show that effector ESAT-6-specific Th1 cells greatly reduce the number of viable M. tuberculosis in the lungs and that control of bacterial growth occurs after day 7 following infection. This delay in protection is unlikely to be caused by a lack of ESAT-6 synthesis during the first week of infection, because ESAT-6 transcript was detectable by at least day 5 after infection in the lungs of infected mice, and ESAT-6-deficient M. tuberculosis showed reduced growth in the lungs (compared with wild-type M. tuberculosis) during the first 5 d of infection, demonstrating that ESAT-6 is synthesized very early after infection (32, 33).
###end p 34
###begin title 35
DISCUSSION
###end title 35
###begin p 36
###xml 56 71 56 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 211 212 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 340 355 340 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 56 71 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 340 355 <span type="species:ncbi:1773">M. tuberculosis</span>
We generated mice tg for a TCR specific to the dominant M. tuberculosis antigen ESAT-6 to investigate the ability of Th1 cells to provide protective immunity. Our analysis of adoptively transferred C7 TCR tg CD4+ T cells revealed that priming of naive ESAT-6-specific TCR tg cells occurred 7-10 d after aerosol infection with a low dose of M. tuberculosis. Our experiments demonstrated that adoptively transferred Th1 cells specific for ESAT-6 can provide a high level of protection, as measured up to 90 d after infection, but that in vivo mycobacterial growth is unimpaired for the first week of infection despite large numbers of pathogen-specific T cells in the lungs.
###end p 36
###begin p 37
###xml 112 127 112 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 252 254 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 256 258 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 314 316 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 358 359 346 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 384 399 372 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 486 487 474 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 759 761 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 112 127 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 384 399 <span type="species:ncbi:1773">M. tuberculosis</span>
The delay in priming of naive ESAT-6-specific T cells is not unexpected and is consistent with the finding that M. tuberculosis-specific effector T cells are not present at high frequencies in the lungs of mice until approximately3 wk after infection (24, 25). Our results are also consistent with a recent study (34) that monitored the priming of TCR tg CD4+ T cells specific to the M. tuberculosis antigen Ag85B. One notable difference is that priming of Ag85B-specific monoclonal CD4+ T cells occurred at day 12 after aerosol infection, 2-4 d later than the C7 TCR tg cell response documented in this study. Differences in priming between naive Ag85B and ESAT-6-specific clones may result from differences in the expression patterns of these two proteins (32), differences in the presentation of these antigens, or differences in the sensitivity of the TCRs used by Ag85B TCR tg cells and C7 TCR tg cells for their cognate antigens. Direct comparative studies will be required to distinguish between these possibilities.
###end p 37
###begin p 38
###xml 164 179 164 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 164 179 <span type="species:ncbi:1773">M. tuberculosis</span>
Our studies with in vitro-generated Th1 cells revealed two surprising findings. One is how well monoclonal ESAT-6-specific Th1 cells were able to protect mice from M. tuberculosis infection. The second is the fact that despite high numbers of C7 Th1 effector cells in animals before infection, bacterial replication was not controlled until 1 wk after infection.
###end p 38
###begin p 39
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 413 428 413 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 441 442 441 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 450 451 450 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 669 684 669 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 413 428 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 669 684 <span type="species:ncbi:1773">M. tuberculosis</span>
The 2-log reduction in the number of bacilli in animals that received C7 Th1 cells is greater than that observed after BCG immunization and comparable to prime-boost vaccination methods (35, 36). By using adoptively transferred C7 Th1 cells, our experiments demonstrate that monoclonal T cells specific to ESAT-6 can provide a level of early protection that is comparable to that provided by mixed populations of M. tuberculosis-specific CD4+ and CD8+ effector T cells after vaccination. Thus, complex populations of T cells are not required to control infection, a result that suggests that adoptive T cell transfer may provide a therapeutic option for drug-resistant M. tuberculosis infections.
###end p 39
###begin p 40
###xml 82 97 82 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 259 274 259 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 278 279 278 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 418 433 418 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 561 576 561 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 82 97 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 259 274 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 418 433 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 561 576 <span type="species:ncbi:1773">M. tuberculosis</span>
It is presumed that improved vaccines can be designed to protect individuals from M. tuberculosis infection by eliciting robust antigen-specific T cell responses. This view is supported by the observation that after aerosol infection in mice, accumulation of M. tuberculosis CD4+ T cells in the lungs coincides with the control of bacterial growth (6, 14, 37). Several hypotheses for a lack of sterilizing immunity to M. tuberculosis can be proposed, including a delayed recruitment of effector T cells to the lungs. Our ability to track adoptively transferred M. tuberculosis-specific C7 Th1 cells allowed us to determine that approximately a half million of these cells were in the lungs before infection and allowed us to definitively rule out this hypothesis.
###end p 40
###begin p 41
###xml 152 167 152 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 774 776 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 152 167 <span type="species:ncbi:1773">M. tuberculosis</span>
What accounts for the delayed protection by C7 Th1 cells? Given the low dose infection used in our studies (100 bacteria) and the slow doubling time of M. tuberculosis during the first several days of infection, very few cells may be infected, and the probability of C7 Th1 cells "finding" an infected cell may be low. Although several cell types, including macrophages and DCs, are infected by day 14 after infection (38), no information exists on the frequency or phenotype of infected cells in the lungs during the first week of infection (although presumably alveolar macrophages are the first cells infected). A recent study using multiphoton microscopy found that liver-resident macrophages, Kupffer cells, were the first cells infected with BCG after i.v. infection (39). Recruitment of uninfected Kupffer cells and blood-derived monocytes to infected cells occurred 2 wk after infection.
###end p 41
###begin p 42
###xml 63 78 63 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 435 436 435 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 606 607 606 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 63 78 <span type="species:ncbi:1773">M. tuberculosis</span>
If similar delays in cell recruitment occur in the lungs after M. tuberculosis infection, it could take 7-10 d until lung resident cells (i.e., macrophages, DCs, and effector/memory T cells) home to infected cells. Before day 7 after infection, C7 Th1 cells may randomly encounter infected cells, whereas after day 7, migration within the lungs to infected sites could be directed by inflammatory signals. Our studies with naive C7 CD4+ T cells demonstrated that T cell priming in pLNs also occurred only after day 7 following infection. A similar mechanism may account for the delayed priming of naive CD4+ T cells. After the first week of infection, DCs and other APCs may home to infected sites within the lung and traffic to draining LNs to prime naive T cells. This hypothesis requires further investigation.
###end p 42
###begin p 43
###xml 153 154 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 262 263 262 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 411 412 407 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 535 537 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib40">40</xref>
###xml 538 540 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
On the other hand, if C7 Th1 cells home to infected cells within the lungs promptly after infection, it would suggest defective collaboration between CD4+ effector cells and infected cells: infected cells may be unable to present antigen to activate effector CD4+ T cells, or infected cells may be unable to control bacterial replication after stimulation by IFN-gamma and other factors provided by effector CD4+ T cells. In vitro studies support both hypotheses, but in vivo studies to answer these important questions are necessary (40-45).
###end p 43
###begin p 44
###xml 94 109 94 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 259 274 259 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 458 473 458 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 523 538 523 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 564 565 564 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 94 109 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
###xml 259 274 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 458 473 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 523 538 <span type="species:ncbi:1773">M. tuberculosis</span>
The findings reported in this paper have important implications for understanding immunity to M. tuberculosis. In this study, we show that high numbers of ESAT-6-specific Th1 cells provided substantial protection to mice after low dose aerosol infection with M. tuberculosis. However, this protection was delayed until after day 7 following infection, and bacteria persisted in these animals thereafter. This finding may help explain why vaccination against M. tuberculosis has been difficult: immediately after infection, M. tuberculosis resides in cells that CD4+ T cells cannot help.
###end p 44
###begin title 45
MATERIALS AND METHODS
###end title 45
###begin title 46
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Generation of C7 TCR tg mice.
###end title 46
###begin p 47
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 108 123 96 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 161 162 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 468 469 455 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 542 543 529 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 649 653 636 640 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1-20</sub>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 108 123 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 906 910 <span type="species:ncbi:10090">mice</span>
To generate ESAT-6-specific CD4+ T cell hybridomas, B6 mice were aerosol infected with approximately100 CFU M. tuberculosis Erdman, and 6 wk after infection, CD4+ splenocytes were purified and stimulated in the presence of irradiated T cell-depleted splenocytes (APCs) and 0.5 mug/ml of ESAT-6 protein (the expression vector used to make ESAT-6 protein, pMRLB7, was provided by Mycobacteria Research Laboratories at Colorado State University). 2 d later, activated CD4+ T cells were fused with the tumor cell line BW5147. Antigen-specific CD4+ T cell hybridomas were selected by screening for IL-2 production in response to ESAT-6 protein and ESAT-61-20 peptide. TCR chains were identified by a combination of surface staining with a panel of TCR Valpha and Vbeta chain monoclonal antibodies (BD Biosciences), and by RT-PCR amplification and DNA sequencing. Hybridoma clone 7 was chosen to generate TCR tg mice because it expressed only one in-frame TCR alpha chain, and monoclonal antibodies were available for both TCR chains. The TCR chains conferring the specificity of clone 7 hybridoma cells were identified as Vbeta10b-Dbeta1.1-Jbeta2.4 and Valpha11.2-Jalpha27. TCR alpha chain variable region (VJ) and beta chain variable region (VDJ) cDNAS were amplified with the following primers: Vbeta10b-Dbeta1.1-Jbeta2.4, (5' primer) 5'-tgctgccctcgaggatcgacgaattcacaggggccatgcagaggaa-3' and (3' primer) 5'-agcaggttccggattctggatgtttgg-3'; and Valpha11.2-Jalpha27, (5' primer) 5'-tgctgcctcgaggatcgacgaattcgacccaactatgggctgta-3' and (3' primer) 5'-tttctcagatcttctagcaccgatagtcgg-3'.
###end p 47
###begin p 48
###xml 311 313 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
VJ and VDJ cDNAS were subcloned into pBluescript vectors that contained TCR alpha or beta chain constant regions. Complete TCR alpha and beta chains were excised and cloned into the VA hCD2 vectors (pBluescript and VA hCD2 were provided by E. Huesby, University of Massachusetts Medical School, Worcester, MA) (23). DNA fragments containing the TCR cDNAs were injected into fertilized B6 oocysts. Founders and their progeny were screened by flow cytometry for surface expression of Vbeta10b and Valpha11.1/.2. TCR tg founder number 27 was selected and used in all experiments presented in this paper.
###end p 48
###begin title 49
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice and adoptive cell transfers.
###end title 49
###begin p 50
###xml 251 254 251 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 292 295 292 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 476 477 476 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 3 7 <span type="species:ncbi:10090">mice</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
B6 mice were purchased from the Jackson Laboratory. All animal procedures were approved by the Memorial Sloan-Kettering Institutional Animal Care and Use Committee. C7 TCR tg mice were bred to B6.CD90.1 mice to obtain C7 TCR tg.CD90.1 mice, and to RAG-/-.CD90.1 mice to generate C7 TCR tg.RAG-/-.CD90.1 mice. C7 TCR tg mice were maintained at the animal facility in the Memorial Sloan-Kettering Research Animal Resource Center. For adoptive transfer experiments, C7 TCR tg CD4+ T cells were isolated from the spleen and LNs of TCR tg mice. Cells were injected i.v. into naive recipients 1 d before infection. In some experiments cells were labeled with 5 muM CFSE before transfer.
###end p 50
###begin title 51
Generation of Th1 cells.
###end title 51
###begin p 52
###xml 6 7 6 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 30 31 30 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 66 67 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 126 130 125 129 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1-20</sub>
###xml 498 499 496 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 523 524 521 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 552 556 <span type="species:ncbi:10090">mice</span>
###xml 723 727 <span type="species:ncbi:10090">mice</span>
3 x 106 purified C7 TCR tg CD4+ T cells were cultured with 12 x 106 irradiated T cell-depleted splenocytes. 5 mug/ml of ESAT-61-20 peptide, 10 ng/ml IL-12, and 5 mug/ml of neutralizing anti-IL-4 antibody (R&D Systems) were added at day 0 of culture. At days 2 and 3 of culture, the cells were split 1:2, and 50 U/ml IL-2 was added (R&D Systems). On day 4 of culture, Th1 cell differentiation was confirmed via intracellular expression of T-bet. The same protocol was used to make polyclonal Th1 CD4+ T cells, except the CD4+ T cells were taken from B6 mice and stimulated in the presence of 1 mug/ml anti-CD3 (145-2C11) and 0.5 mug/ml anti-CD28 (37.51). Th1 cells were washed three times with PBS and injected i.v. into B6 mice.
###end p 52
###begin title 53
In vitro T cell proliferation and IL-2 production.
###end title 53
###begin p 54
###xml 6 7 6 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 133 134 133 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 256 260 256 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1-20</sub>
###xml 378 379 377 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 676 681 <span type="species:ncbi:10090">mouse</span>
5 x 104 clone 7 hybridoma cells, BW5147 cells, or purified CD4+ T cells harvested from B6 or C7 TCR tg mice were plated with 1.5 x 105 irradiated T cell-depleted splenocytes in 96-well round-bottom plates in the presence of various concentrations of ESAT-61-20 peptide. For proliferation experiments, cells were pulsed between days 2 and 3 of culture by the addition of 1 muCi [3H]thymidine per well for 16 h before harvesting cells onto glass-fiber filters and determining the incorporated radioactivity using a liquid scintillation counter (TopCount; PerkinElmer). For IL-2 ELISAs, supernantants were harvested after 2 d of stimulation, and IL-2 levels were measured with a mouse IL-2 ELlSA set (BD Biosciences).
###end p 54
###begin title 55
Intracellular staining.
###end title 55
###begin p 56
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 219 223 218 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1-20</sub>
###xml 427 442 426 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 427 442 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 736 741 <span type="species:ncbi:10090">mouse</span>
###xml 816 821 <span type="species:ncbi:10090">mouse</span>
To detect intracellular cytokines 3 x 106 cells from pLNs, spleen, or collagenase-digested and -perfused lungs were plated in 96-well round-bottom plates in the presence of GolgiPlug (BD Biosciences) and 5 mug/ml ESAT-61-20 peptide. 5 h later, cells were washed and stained with cell-surface antibodies, and intracellular cytokine (ICC) staining was performed according to the manufacturer's instructions. Cells harvested from M. tuberculosis-infected mice were fixed with 2% paraformaldehyde overnight before removal from the biosafety level 3 facility. These cells were washed and permeabilized, and ICC staining was performed. Intracellular T-bet and isotype control staining (anti-T-bet-PE 4B10 [Santa Cruz Biotechnology, Inc.] and mouse IgG1-PE [BD Biosciences]) were performed using reagents supplied with the mouse regulatory T cell staining kit (eBioscience).
###end p 56
###begin title 57
###xml 24 39 24 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 24 39 <span type="species:ncbi:1773">M. tuberculosis</span>
Aerosol infections with M. tuberculosis.
###end title 57
###begin p 58
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 92 93 92 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 93 108 93 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M. tuberculosis</italic>
###xml 817 818 799 800 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 15 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
M. tuberculosis Erdman was grown in 7H9 media, and log-phase cultures were diluted to 8 x 106M. tuberculosis per millimeter and were sonicated before infection with an aerosol exposure system (Glass-Col). 8-10-wk-old B6 mice were infected with a volume of suspension, and exposure time was calibrated to deliver approximately100 CFU per animal. To determine the infection dose, three mice were killed 1 d after infection and lungs were harvested and homogenized in PBS/0.05% Tween-80, and half of the lung homogenate was plated. At various time intervals after infection, the right lung was harvested from individual mice and homogenized in PBS/0.05% Tween-80. Serial dilutions were made in PBS/0.05% Tween-80 and plated onto Middlebrook 7H10 agar (BD Biosciences). After 3-4 wk of incubation at 37degreesC in a 5% CO2 atmosphere, mycobacterial colonies were counted and the bacterial numbers in the lungs were calculated.
###end p 58
###begin title 59
Real-time PCR analysis.
###end title 59
###begin p 60
###xml 53 56 53 56 <sc xmlns:xlink="http://www.w3.org/1999/xlink">zol</sc>
###xml 330 338 330 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifn&#947;</italic>
###xml 343 347 339 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nos2</italic>
###xml 527 535 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifn&#947;</italic>
###xml 540 544 532 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nos2</italic>
###xml 637 645 629 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifn&#947;</italic>
###xml 723 749 711 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink">n = Ct ifn&#947; &#8722; Ct GAPDH</sup>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
Total RNA was isolated from lung parenchyma using TRIzol reagent (Invitrogen), and cDNA was synthesized from DNase-treated RNA using oligo(dT) primers and SuperScript II (Invitrogen). RNA was pooled from four mice per group. SYBR green-based real-time PCR analysis was performed using the DynNAmo SYBR green qPCR kit (Finnzymes). ifngamma and nos2 primers were purchased from QIAGEN. Signals were normalized to GAPDH transcript (forward, 5'-ACCACAGTCCATGCCATCAC-3'; reverse, 5'-TCCACCACCCTGTTGCTGTA-3'). To determine levels of ifngamma and nos2, the following equation was used, where n equals the difference in PCR cycle number between ifngamma and GAPDH at which the signals were first detected above background (Ct): 1/2n = Ct ifngamma - Ct GAPDH.
###end p 60
###begin title 61
Statistical analysis.
###end title 61
###begin p 62
###xml 63 64 63 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Statistical analysis was performed with the unpaired Student's t test on Prism software. P </= 0.05 was considered significant. Error bars denote SDs.
###end p 62
###begin title 63
Online supplemental material.
###end title 63
###begin p 64
###xml 234 242 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ifn&#947;</italic>
###xml 247 251 243 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nos2</italic>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
Fig. S1 A shows CD69 and CD25 expression on gated C7 Th1 cells harvested from the lungs of naive and infected mice. Fig. S1 B shows numbers of recoverable C7 Th1 cells from infected mice. Fig. S1 C depicts a real-time PCR analysis of ifngamma and nos2 transcripts from the lungs of infected mice. Online supplemental material is available at .
###end p 64
###begin p 65
We are grateful to Natalya Serbina, Amaraliz Rivera, and Tobias Hohl for helpful discussions and/or comments on the manuscript, and Feng Gao and Ingrid Leiner for technical support.
###end p 65
###begin p 66
###xml 97 105 <span type="species:ncbi:558547">Gallegos</span>
This research was supported by a National Institutes of Health (NIH) F32 grant (AI074248 to A.M. Gallegos) and NIH grants (AI53417 to M. Glickman and AI0677359 to E. Pamer). We received pMRLB7 as part of a National Institute of Allergy and Infectious Diseases, NIH contract (HHSN266200400091C) entitled "Tuberculosis Vaccine Testing and Research Materials," which was awarded to Colorado State University.
###end p 66
###begin p 67
The authors declare that they have no competing financial interests.
###end p 67

